1-3 of 3
Joanna Czerwinska-Rybak
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Significance of Chromosome 11 Abnormalities in Patients with AML

Anna Przybylowicz-Chalecka, Joanna Czerwinska-Rybak, Blazej Ratajczak, Zuzanna Kandula, Andrzej Szczepaniak, Malgorzata Jarmuz-Szymczak, Lidia Gil
Journal: Blood
Blood (2021) 138 (Supplement 1): 4451.
https://doi.org/10.1182/blood-2021-152308
Published: 2021
Journal Articles

Comparative Proteomic Profiling of Sera from Patients with Refractory Multiple Myeloma Reveals Pathways and Biomarkers Predicting Response to Bortezomib-Based Therapy

Dominik Dytfeld, MD PhD, Magdalena Luczak, PhD, Tomasz Szczepaniak, MD, Anna Przybylowicz-Chalecka, Msc, Blazej Ratajczak, MSc, Joanna Czerwinska-Rybak, MSc, Adam Nowicki, MD PhD, Monika Joks, MD PhD, Andrzej Jakubowiak, MD PhD, Mieczyslaw Komarnicki, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2092.
https://doi.org/10.1182/blood.V128.22.2092.2092
Published: 2016
Journal Articles

Comparative Proteomic Profiling of Refractory/Relapsed Multiple Myeloma Patient Plasma Cells Reveals Biomarkers and Pathways Involved in Bortezomib-Based-Therapy Resistance

Dominik Dytfeld, MD PhD, Magdalena Luczak, PhD, Anna Przybylowicz-Chalecka, Msc, Blazej Ratajczak, MSc, Adam Nowicki, MD, Joanna Czerwinska-Rybak, MSc, Monika Joks, MD PhD, Tomasz Szczepaniak, MD PhD, Bochenek Maciej, Andrzej Jakubowiak, MD PhD, Mieczyslaw Komarnicki, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2986.
https://doi.org/10.1182/blood.V126.23.2986.2986
Published: 2015